These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 23484757)
21. [Front-line drug discovery system for cancer]. Mizukami T Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393 [TBL] [Abstract][Full Text] [Related]
22. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes]. Zhang DL; Ji L; Li YD Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601 [TBL] [Abstract][Full Text] [Related]
23. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
24. Phenotype-first screening for the identification of novel drug targets. Austen M; Dohrmann C Drug Discov Today; 2005 Feb; 10(4):275-82. PubMed ID: 15708746 [TBL] [Abstract][Full Text] [Related]
26. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
27. Genomics: success or failure to deliver drug targets? Betz UA; Farquhar R; Ziegelbauer K Curr Opin Chem Biol; 2005 Aug; 9(4):387-91. PubMed ID: 15990354 [TBL] [Abstract][Full Text] [Related]
28. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
29. A decade of fragment-based drug design: strategic advances and lessons learned. Hajduk PJ; Greer J Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284 [TBL] [Abstract][Full Text] [Related]
30. [Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/2nd communication: promising strategies]. Kuhlmann J Arzneimittelforschung; 2004; 54(6):307-13. PubMed ID: 15282874 [TBL] [Abstract][Full Text] [Related]
31. How molecular profiling is transforming drug discovery. Stoughton RB Discov Med; 2005 Jun; 5(27):247-52. PubMed ID: 20704883 [TBL] [Abstract][Full Text] [Related]
32. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice. Ross JS; Ginsburg GS Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694 [TBL] [Abstract][Full Text] [Related]
33. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent. Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940 [TBL] [Abstract][Full Text] [Related]
34. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme. Bjerrum OJ Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750 [TBL] [Abstract][Full Text] [Related]
35. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
36. Global gene mining and the pharmaceutical industry. Knudsen LE Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):679-83. PubMed ID: 15979678 [TBL] [Abstract][Full Text] [Related]
37. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization]. Santiago-Delefosse M; Cahen F; Coeffin-Driol C Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699 [TBL] [Abstract][Full Text] [Related]